史蒂夫·马登 SHOO 深 沪
等待开盘 12-19 09:30:00 美东时间
42.90
+0.010
+0.02%
华盛通- 最 高43.49
- 今 开43.12
- 成交量 131.77万股
- 最 低 42.43
- 昨 收 42.89
- 总市值 31.17亿
- 52周最高 44.78
- 市盈率 静 18.23
- 换手率 1.81%
- 52周最低 18.42
- 委 比 64.00%
- 总股本 7265.24万
- 历史最高 48.96
- 量 比 1.29
- 振 幅 2.47%
- 历史最低 12.42
- 每 手 1
- 风险率 7.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
BTIG Maintains Buy on Steven Madden, Raises Price Target to $50
BTIG analyst Janine Stichter maintains Steven Madden (NASDAQ:SHOO) with a Buy and raises the price target from $43 to $50.
12-04 19:11
Shares of broader retail stocks are trading higher following strong earnings from Gap and Ross Stores. Additionally, stocks across sectors are rising amid hopes for a December rate cut following earlier Fed comments.
Shares of broader retail stocks are trading higher following strong earnings fr...
11-21 23:05
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Telsey Advisory Group Maintains Outperform on Steven Madden, Raises Price Target to $45
Telsey Advisory Group analyst Dana Telsey maintains Steven Madden (NASDAQ:SHOO) with a Outperform and raises the price target from $43 to $45.
11-06 21:04
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
What's Going On With Steven Madden Stock Today?
Steven Madden jumped ~7% as tariff-driven wholesale softness led to Q3 misses, but above-consensus Q4 EPS ($0.41–$0.46) and sales ($739.5M–$757.0M) guidance lifted the outlook.
11-06 00:44
Steven Madden Q3 Adj. EPS $0.43 Misses $0.44 Estimate, Sales $667.875M Miss $696.199M Estimate
Steven Madden (NASDAQ:SHOO) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.44 by 1.83 percent. This is a 52.75 percent decrease over earnings of $0.91 per share from the
11-05 19:59
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
